<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chemotherapy can cause immunosuppression, which may trigger latent intestinal <z:e sem="disease" ids="C0747256" disease_type="Disease or Syndrome" abbrv="">parasitic infections</z:e> in stools to emerge </plain></SENT>
<SENT sid="1" pm="."><plain>This study investigated whether <z:e sem="disease" ids="C0021832" disease_type="Disease or Syndrome" abbrv="">intestinal parasites</z:e> can emerge as <z:e sem="disease" ids="C0029118" disease_type="Disease or Syndrome" abbrv="">opportunistic infections</z:e> in breast and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients (n=46 and n=15, respectively) undergoing chemotherapy treatment </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003002'>Breast cancer</z:hpo> patients were receiving a <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>/<z:chebi fb="0" ids="47898">epirubicin</z:chebi>/<z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (FEC) regimen (6 chemotherapy cycles), and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients were receiving either an <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>/<z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>/folinic acid (FOLFOX) regimen (12 cycles) or a <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>/folinic acid (Mayo) regimen (6 cycles) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients had Blastocystis hominis and <z:e sem="disease" ids="C0085407" disease_type="Disease or Syndrome" abbrv="">microsporidia infections</z:e> that were only present during the intermediate chemotherapy cycles </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients undergoing chemotherapy should be screened repeatedly for <z:e sem="disease" ids="C0021832" disease_type="Disease or Syndrome" abbrv="">intestinal parasites</z:e>, namely B. hominis and microsporidia, as they may reduce the efficacy of chemotherapy treatments </plain></SENT>
</text></document>